[ Back to EurekAlert! ]

Contact: Morwenna Grills
University of Manchester

Cancerous B Cells Treated with Rituximab

Caption: This image shows cancerous B cells that have been treated with rituximab. The protein CD20 (shown in green) has been drawn to the side of the cells. When the Natural Killer white blood cells approach they will stand an 80 percent chance of killing the cell if they latch on to the side where the protein has collected.

Credit: MCCIR

Usage Restrictions: None

Related news release: Video reveals cancer cells' Achilles' heel

[ Back to EurekAlert! ]